Cardiovascular Information System Market Analysis and Forecast Report 2024

The global cardiovascular information system market is witnessing significant growth due to increasing prevalence of cardiovascular diseases, growing government initiates towards electronic health record system implementation and growing rate of medication errors. The remote access to data and images, and reduced IT burden in the diagnostic center and hospitals are supporting the demand of CVIS. Moreover, better interoperability and increasing healthcare cost are further expected to boost the market.

Get report sample at: https://www.psmarketresearch.com/market-analysis/cardiovascular-information-system-market/report-sample

Based on mode of operation, web-based segment leads the global market in terms of size, owing to high rate of awareness, improved interoperability, reduced IT burden in hospitals and relatively less cost. Based on component, the market for service segment is expected to grow at the fastest rate during the forecast period, due to upgradation of services for the complex software introduction and requirement for extensive training.

Cardiovascular disease is the disease of heart and blood vessels, which includes conditions such as hypertension, coronary heart disease, heart failure, cerebrovascular disease and rheumatic heart disease. It is the leading cause of premature death around the world. According to the WHO, globally about 17.5 million people died due to cardiovascular diseases in 2012, while the number is expected to reach 23.3 million by 2030.

Globally, the cardiovascular information system market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to large pool of patient, improving healthcare infrastructure, increasing incidence of cardiovascular disease, and growing medical tourism in the region.

The key players operating in the global cardiovascular information system market are Philips Healthcare, McKesson Corporation, General Electric Company, Siemens AG, AGFA Healthcare and Cerner Corporation.

Source: P&S Intelligence

Top Key Players Operating In the Healthcare EDI Market and Growth Strategies

Healthcare electronic data interchange (EDI) facilitates the exchange of healthcare data which is processed using computer software in a standardized format. Healthcare industry processes a large number of documents such as medical records of patients, healthcare claims, and reimbursement records. Healthcare EDI helps in the exchange of this information among healthcare institutions, healthcare professionals, and patients. The use of healthcare EDI increases accuracy, improves productivity, helps in faster identification of errors, consumes less time, secures exchange of information and leads to ease of work for the healthcare providers, healthcare payers, and pharmacies. Healthcare EDI finds application in insurance and reimbursement data management, clinical trials and regulatory data management, and medical and dental patient database management. They key players such as Dell Technologies Inc. are prompting the growth of the global healthcare EDI market. In February 2017, Dell Technologies Inc. quickened the digital transformation in healthcare EDI market with the introduction of cloud integration solution for healthcare EDI.

Get report sample at: https://www.psmarketresearch.com/market-analysis/healthcare-edi-market/report-sample

Global healthcare EDI market is expected to grow significantly during the forecast period. Some of the major factors driving growth of the market include expanding base of patient due to the increasing prevalence of chronic diseases, rising need to curtail healthcare costs, and government support for healthcare EDI. According to the World Health Organization (WHO), chronic disease is the leading cause of mortality globally, comprising 60% of all deaths. Also, approximately 17.7 million people died from cardiovascular diseases in 2015, representing 31% of all global deaths. Of these deaths, an approximate of 7.4 million deaths were due to coronary heart disease and 6.7 million were due to stroke. WHO also reported that globally 8.8 million people died from cancer which is 1 in 6 of all global deaths in 2015. With the rise in these chronic diseases, the volume of patient is also increasing. Moreover, these large number of deaths also prompts the end users to avail healthcare EDI products for different reimbursements claims.

The key trend witnessed in the global healthcare EDI market is increasing number of research and development activities. With the rising prevalence of adoption of advanced technology in the healthcare market, the key players are investing more on the research and development on healthcare EDI, for the growth of the global healthcare EDI market. Additionally, increasing use of EDI in healthcare manufacturing and distribution industry and growing focus on integration platform as a service (IPAAS) are major trends observed in the global healthcare EDI market. The increase in outsourcing of EDI services and introduction of ICD-11 guidelines are creating ample opportunities for the growth of the global healthcare EDI market.

Browse full report at: https://www.psmarketresearch.com/market-analysis/healthcare-edi-market

Some of the key players in the global healthcare EDI market are GE Healthcare, Cognizant Technology Corporation, Cerner Corporation, Axway Software SA, Dell Technologies Inc., Synnex Corporation, McKesson Corporation, Allscripts Healthcare Solutions Inc., SSI Group, LLC, Comarch SA, Optum Inc., and Quality Systems Inc.

Source: P&S Intelligence

Europe Cleanroom Technology Market Analysis with Key Players and Forecast Report 2023

The Europe cleanroom technology market is forecasted to generate $1,701.8 million revenue by 2023. The market is mainly driven by increasing number of conferences, seminars, and events for cleanroom technology, growing infectious diseases, and increasing healthcare expenditure in the region.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/europe-cleanroom-technology-market/report-sample

The different types of products available in the European cleanroom technology market are cleanroom consumables and equipment. The market for cleanroom consumables is expected to observe faster growth, witnessing a CAGR of more than 7.0% during the forecast period. The growth is mainly driven by the increasing adoption of these products to maintain aseptic environment in various industries, such as pharmaceutical, biotechnology, and medical devices; hospitals; and research laboratories.

On the basis of construction, the European cleanroom technology market is categorized into standard, hardwall, softwall, and pass-through cleanrooms. Hardwall cleanrooms is expected to be the fastest growing category in this market, exhibiting a CAGR of more than 7.5% during the forecast period. This growth is mainly due to increasing research and development (R&D) of pharmaceuticals in the region, which involves the use of hardwall cleanrooms, specifically designed for research activities.

Pharmaceutical, biotechnology, and medical devices industries generate huge demand for cleanroom technology products. Various pharmaceutical and biotechnology products, such as vaccines, injections, biologics, and ointments, need to be prepared in an environment that is free from microbes and particulates. Cleanroom offers suitable environmental conditions by lowering the level of pollutants, such as dust, chemical vapors, microbes, and aerosol particles.

Some of the other players in the European cleanroom technology industry include M+W Group GmbH, Ardmac Ltd., Alpiq Holding Ltd., cleanroom.de GmbH, OCTANORM-Vertriebs-GmbH, MonMouth Scientific Ltd., Cleanroom Systems Belgium, Parteco Srl, Mach-Aire Ltd., E.I. du Pont de Nemours and Company, Kimberly-Clark Corporation, Taikisha Ltd., and Illinois Tool Works Inc.

Source: P&S Intelligence

Animal Vaccines Market and its Growth Landscape for the Next Few Years

Vaccines have proven to be a boon for animal health in veterinary medicine. With increase in the number of adoption cases of companion animals globally, vaccination has become important for these animals as they suffer from various diseases. Strong focus on the development of needle-free DNA animal vaccines and ongoing research on plant-based animal vaccines have added to the growth of the market.

Get report sample at: https://www.psmarketresearch.com/market-analysis/animal-vaccines-market/report-sample

Other than this, growth in livestock population and repeated outbreaks of life-stock diseases; rising incidence of zootonic diseases; introduction of new vaccines; and government initiatives by various agencies, animal associations, and major market players are also boosting the growth of the global animal vaccines market.

Geographically, North America is expected to lead the global animal vaccines market in the coming years, owing to the stringent regulations for vaccines production, increasing awareness against the use of antimicrobials, and rising number of innovations in developing vaccines for animals in the region.

Various factors, including, rising technological innovations and introduction of innovative vaccines; such as DNA, and recombinant vaccines; improved healthcare facilities; and growing investment by government bodies are positively impacting the growth of this market. Recombinant vaccines represent an innovative option to overcome the limitations of conventional vaccines, since these can be produced efficiently in large amounts and usually present low reactogenicity and toxicity.

Browse full report at: https://www.psmarketresearch.com/market-analysis/animal-vaccines-market

Ongoing partnerships and product approvals in the industry are expected to increase the market share of the players in the coming years. For instance, in September 2018, U.S. Department of Agriculture (USDA) granted an expanded indication to Cytopoint, a novel monoclonal antibody (mAb) therapy by Zoetis Inc., for the treatment of allergic dermatitis in dogs. Cytopoint is the first mAb therapy licensed to treat allergic as well as atopic dermatitis, an indication for which it was fully licensed by the USDA in 2016.

Other than Zoetis Inc, the animal vaccines industry is marked by the presence of market players, such as Merck & Co. Inc., C.H. Boehringer Sohn AG & Ko. KG, Eli Lilly and Company, Ceva Santé Animale S.A., Virbac Group, Bayer AG, Vetoquinol S.A., Phibro Animal Health Corporation, and Hester Biosciences Limited.

Source: P&S Intelligence

High-Throughput Screening Market Rising Growth and Future Analysis

The global high-throughput screening market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure, increasing research and development activities, launch of technologically advanced products that are miniaturized and automated and growing popularity of high-throughput screening for drug discovery. Moreover, high adoption of high-throughput screening models in pharmaceutical and biotechnology companies across the globe is supporting the growth of the market. Based on technology, 2D cell culture segment is expected to grow at the fastest rate during the forecast period owing to its low cost and ease of use.

Request for report sample at: https://www.psmarketresearch.com/market-analysis/high-throughput-screening-market/report-sample

The rapid growth in emerging economies and growing research and development activities on stem cells and toxicology is expected to create opportunities for the manufacturers of high-throughput screening products. However, high cost of high-throughput screening, lack of trained professionals and complexity in assay development are the key factors hampering the growth of the global market.

High-throughput screening is a method that uses automation and large dataset processing to quickly assay the biological activity of large numbers of compounds, proteins and genes. High-throughput screening is used for drug discovery, target identification, biochemical screening, protein stabilization, and cell and organismal-based screening. It helps in optimizing substrate concentration, protein concentration and identification of physiologically relevant controls.

Browse full report at: https://www.psmarketresearch.com/market-analysis/high-throughput-screening-market

Geographically, North America has been the largest market for high-throughput screening, owing to its increased awareness, increasing government funding, established healthcare industry, and easy accessibility to advanced technologies due to the awareness in the region. The U.S. contributed largest revenue to the North American as well as global high-throughput screening market. The increased research and development activities and increasing prevalence of chronic diseases arising the need for novel treatments is the key growth driving factor for the U.S. high-throughput screening market.

The key players operating in the global market are Agilent Technologies, Inc, Danaher Corporation, Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Hamilton Company and Aurora Biomed, Inc.

Source: P&S Intelligence